Clinical Trial: Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152678) titled 'Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma' on Aug. 26.

Brief Summary: The goal of this clinical trial is to learn if adding high-dose-rate (HDR) brachytherapy can improve outcomes in patients with locally advanced esophageal squamous cell carcinoma (ESCC) who have already received external beam radiotherapy (EBRT), chemotherapy, and the immune therapy drug nivolumab.

The main questions it aims to answer are:

* Does HDR brachytherapy reduce the chance of the cancer coming back in the esophagus or nearby areas within 12 months?

* What side effects or safety issues occu...